Susana Millán

Efficacy of Single-Dose Antibiotic Against Early-Onset Pneumonia in Comatose Patients Who Are Ventilated

Jordi Vallés, R. Peredo, Maria Jose Burgueño et al. · CHEST Journal · 2013 · 80 citations

Antibiotics, Antimicrobial Stewardship, Klebsiella Pneumoniae +4

Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial

Álvaro Romera, Sergiy Peredpaya, Yaroslav Shparyk et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 61 citations

Medicine, Metastatic Colorectal Cancer, Pathology +5

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial

Gustavo Lopardo, Waldo Belloso, Esteban C. Nannini et al. · EClinicalMedicine · 2021 · 52 citations · Full text

Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach

Myrna Candelaria, Derlis Gonzalez, Francisco Javier Fernández Gómez et al. · Cancer Chemotherapy and Pharmacology · 2018 · 36 citations · Full text

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)

Dmytro Trukhin, Elena Poddubskaya, Zoran Andrić et al. · BioDrugs · 2021 · 27 citations · Full text